The role of ferroptosis-related non-coding RNA in liver fibrosis
2024

The Role of Ferroptosis-Related Non-Coding RNA in Liver Fibrosis

publication Evidence: moderate

Author Information

Author(s): Zhang Guozhu, Wu Kejia, Jiang Xiaobo, Gao Yuan, Ding Dong, Wang Hao, Yu Chongyuan, Wang Xiaozhong, Jia Naixin, Zhu Li

Primary Institution: The First People’s Hospital of Changzhou, The Third Affiliated Hospital of Soochow University

Hypothesis

Ferroptosis-related non-coding RNAs play a significant role in the progression and treatment of liver fibrosis.

Conclusion

Ferroptosis and its related non-coding RNAs are crucial in the onset and prognosis of liver fibrosis, presenting new therapeutic opportunities.

Supporting Evidence

  • Liver fibrosis is a reversible process, but no specific antifibrotic drugs have been developed yet.
  • Ferroptosis is linked to liver fibrosis and involves various non-coding RNAs.
  • Targeting ferroptosis-related non-coding RNAs could provide new therapeutic strategies for liver fibrosis.

Takeaway

This study talks about how certain types of RNA can help us understand and treat liver scarring, which is a serious health problem.

Limitations

The research primarily relies on cell and animal models, which may limit the physiological relevance of the findings.

Digital Object Identifier (DOI)

10.3389/fcell.2024.1517401

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication